Some illness are caused by an excess of proteins in human cells. Sylentis therapies are based on gene silencing technology. This technology is aimed at reducing the concentration of such proteins.
For this purpose Sylentis uses rationally designed molecules that interfere specifically with the process of creation of proteins in order to achieve gene silencing.
The following figure provides a more detailed explanation:
Click the buttom below for a further explanation about RNAi molecular mechanism: